Evaluating the effects of a traditional Japanese medicine for patients with intestinal cysts
Official title: The Beneficial Effect of the Traditional Japanese Medicine, Keishi-ka-shakuyaku-daio-to（TJ-134）for Patients With Symptomatic Pneumatosis Cystoides
Run by Showa Inan General Hospital · NCT04368663 · Data updated 2026-11-12
This study is testing a traditional Japanese medicine called TJ-134 to see if it can help people with intestinal cysts feel better over 8 weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Showa Inan General Hospital Academic / other |
| Locations | 1 site (Komagane, Nagano) |
| Status | Recruiting |
| Started | May 1, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT04368663 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with symptomatic pneumatosis cystoides intestinalis who exhibit typical findings on colonoscopy.
✕Probably not a fit
Patients who are unable to take Keishi-ka-shakuyaku-daio-to (TJ-134) will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the efficacy of the traditional Japanese medicine Keishi-ka-shakuyaku-daio-to (TJ-134) in treating patients with symptomatic pneumatosis cystoides intestinalis (PCI). Patients are randomly assigned to receive either TJ-134 or a control treatment, lactomin, for a duration of 8 weeks. The study involves initial evaluations of abdominal symptoms and CT scans, followed by reassessment after the treatment period to determine any changes in symptoms and condition. The trial aims to provide insights into the potential benefits of TJ-134 for managing this rare intestinal condition.
Why it matters
Potential benefit: If successful, this treatment could offer a new therapeutic option for patients suffering from symptomatic pneumatosis cystoides intestinalis.
How similar studies have gone: While this approach using traditional Japanese medicine is relatively novel, there may be limited existing studies on similar treatments for pneumatosis cystoides intestinalis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * typical findings of PCI on colonoscopy; Line or pebble like sessile cysts are distributed around the colon with normal overlying mucosa Exclusion Criteria: * patients can not take Keishi-ka-shakuyaku-daio-to（TJ-134）
Where it's running
-
Showa Inan General hospital
Komagane, Nagano, Japan Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.